BridgeBio Oncology Therapeutics, Inc.

BBOT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.7B · 92 employees
25
SEC Filings
$8.84
Close 2026-05-28
92
Employees

Business Summary

PART I Item 1. Bus iness. Overview BBOT is a clinical-stage biotechnology company with the mission of transforming the lives of patients with cancers driven by RAS and PI3K, the two most frequently mutated oncogenes. Aberrant RAS signaling drives uncontrolled tumor growth in some of the deadliest cancers, including lung, breast, pancreas and colon cancer. This can come from mutations in RAS itself, which underlie approximately 30% of all human cancers, or from RAS-mediated overactivation of PI3K...

Latest Stock Quote

BBOT 2026-05-28 $8.84 O:$8.5 H:$8.925 L:$8.41 Vol:0.1M VWAP:$8.7696
origin leaf: 8d547f255b33b8438b2f5bad1fd803d9b0ccb43807b09b8994a53c3d63481e44

Next Earnings

Q2 FY2026 — expected 2026-08-08

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-094112EDGAR111K words
2025-03-112024-12-310001213900-25-022387EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277834EDGAR78K words
2025-08-012025-06-300001213900-25-070659EDGAR—
2025-05-152025-03-310001213900-25-044424EDGAR—
2024-11-142024-09-300001213900-24-098483EDGAR—
2024-08-142024-06-300001213900-24-068630EDGAR—
2024-05-152024-03-310001213900-24-043582EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126493EDGAR1K words
2026-03-050001193125-26-093997EDGAR—
2026-01-070001193125-26-005425EDGAR—
2025-11-120001193125-25-277601EDGAR—
2025-08-130001213900-25-075190EDGAR—
2025-08-060001213900-25-072312EDGAR—
2025-08-040001213900-25-071392EDGAR—
2025-07-110001213900-25-062955EDGAR—
2025-03-030001213900-25-018997EDGAR—
2025-02-280001213900-25-018334EDGAR—

25 total filings indexed. 7 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001869105
TickerBBOT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.bridgebio.com
Listed2025-08-12

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7f4826e12d727cc0f3e0d31834034da362a4ad71e64295826391c0291c6d6cd3
parent: b692c0399f71825cf7a801b55b5d01f61616a17d39e590aa30adcad89592d5b4
content hash: f5bdb9adcd8207c597d9fc346da12ecaa4cd11c3f6f14e0144f1a01a4c2cfd7b
signed: 2026-06-02T19:00:21.980Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf